Navigation Links
Signalife and Heart One Global Research Agree to Merge
Date:7/7/2008

y, (j) Internal Medicine, (k) Neurology, (l) Obstetrics, (m) Occupational health, (n) Orthopedics surgery, (o) Pediatrics, (p) Psychiatry, (q) Rehabilitation, and (r) Sports medicine.

The two companies will be announcing certain distribution and financing transactions in the upcoming couple of days. The transactions are subject to Board approval, and could be subject to shareholder approval if a merger is to be consummated. However, notwithstanding any agreement to the contrary, Heart One Global Research and its affiliates and subsidiaries have agreed to a $10,000,000 break-up fee payable to Signalife, Inc. if the transaction fails to close for any reason other than an act of Signalife.

As Signalife continues to generate data from the usage of its Fidelity 100, the analysis and exchange of this data -- which suggests that screening using the Fidelity 100 yields pathology detection at triple (or more) of the national average rate -- must be properly evaluated, stored and communicated to patient and industry alike. In the words of Lowell Harmison, senior advisor to the Signalife Board, "Is walking around with early asymptomatic heart disease acceptable? We may have now identified a key reason for the astronomical cost reported to be nearly $400 billion nationwide in caring for heart patients." By effectuating the merger, the companies will assure that the core of the electronic medical record -- the condition of the patient's heart -- is properly screened and carefully compared to the other medical and pharmacological conditions across societies.

Under the merger agreement, all shareholders of Heart One Global Research must physically deliver their share certificates to an independent third party tabulator. Concurrently, all shareholders of Signalife must physically deliver their share certificates to the same independent party. Upon receipt of all share certificates, the surviving company -- a subsidiary of Signalife -- shall emanate and such com
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
2. Signalife & Athletes Foundation Complete Second Mobile Health Screening
3. Signalife Establishes Signalcare Division
4. Signalife to Deploy Fidelity 100 Heart Monitors for AFL
5. Geisinger study: PTSD causes early death from heart disease
6. Get Healthy: Your Middle-Aged Heart Will Thank You
7. Gender differences and heart disease
8. WorldHeart Receives Non-Compliance Letter From NASDAQ Stock Market
9. American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August
10. American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing
11. Certain anti-cancer agents could be harmful to patients with heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... The Biofeedback Federation of Europe annual meeting is ... Italy and is hosted by the Salesian Pontifical University. ... wide variety of topics such as ADHD, anxiety, headaches ... athletes. The scientific program will feature the latest in ... clients to see what is going on in their ...
(Date:12/26/2014)... 26, 2014 Pentec Health, Inc. number ... state of Pennsylvania for 2014. The awards program, created ... of its kind in the country. The program is ... Department of Community and Economic Development, the Pennsylvania State ... the Central Penn Business Journal. , Charlie ...
(Date:12/25/2014)... 2014 This is a professional and ... Sterilizers industry with a focus on the Chinese market. ... of the Sterilizers manufacturers and is a valuable source ... in the industry. This report provides a basic overview ... technology. In this part, the report presents the company ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... in an ,all-comer population, researchers say , WEDNESDAY, June ... performed well in a real-life trial, Dutch cardiologists report. ... coated with the drug everolimus -- is inserted to ... and is already in widespread use. It was approved ...
... with Inclusion of General Surgeons, Otolaryngologists and , ... 17 The American College of Surgeons (ACS) supports ... and Zack Space (D-Ohio), which includes the participation of ... Providers Loan Repayment Program called the Access to Frontline ...
... Thing of the Past , , OKEMOS, Mich., ... States and many companies find themselves in a cost-cutting mode ... painful cutbacks that impact valued retirees -- many of whom ... Renaissance Life & Health Insurance Company of America ...
... , JACKSONVILLE, Fla., June 17 Dan Meirson, MD, ... Society of Dermatology and Dermatologic Surgery (FSDDS) at its ... Dr. Meirson was selected for the award in recognition ... the society and the dermatologic profession. , , ...
... home model leads to less emergency room costs and avoidable ... of recent innovations in delivering primary care at a ... success and rapid return on investment. The data led to ... of Group Health,s 26 medical centers by 2010. , ...
... and religion have always been intertwined, most obviously through ... for sick people actually help heal them? For thousands ... Brandeis University research in the Journal of Religion ... decades, medical studies of intercessory prayerthe prayer of strangers ...
Cached Medicine News:Health News:Newest Coated Stent Does Well in Real-World Trial 2Health News:Newest Coated Stent Does Well in Real-World Trial 3Health News:American College of Surgeons Supports Bill to Create New Frontline Providers Loan Repayment Program 2Health News:Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 2Health News:Group Health Cooperative Shows Investing in More Primary Care Pays for Itself 2Health News:Group Health Cooperative Shows Investing in More Primary Care Pays for Itself 3Health News:The power of prayer? 2
(Date:12/24/2014)... /CNW/ -   The ... Canada tests confirmed it contains two undeclared amphetamine-like drug ... The distributor, Empire Health Distribution of Terrebonne, ... stores across Canada .  Jetfuel Superburn ... loss and increased energy. What consumers ...
(Date:12/24/2014)... DUBLIN , Dec. 24, 2014  Actavis ... that the Company has received a complete response ... (FDA) for its New Drug Application (NDA) for ... for the treatment of hypertension.   Photo ... we are disappointed in the receipt of a ...
(Date:12/24/2014)... Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) released unaudited preliminary financial results ... Fiscal Year 2015 Ended September 30, ... million compared with $14.7 million in 1Q14 with ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12
... 2011 A recent paper published in the Journal ... technique to be a fast, objective method to screen for ... transient VEP (SD-tVEP), significantly decreases test duration and provides less ... study was carried out at New York Eye and Ear ...
... 2011 Robbins & Myers, Inc. (NYSE: ... has approved its regular quarterly cash dividend payment of ... 5, 2011 to shareholders of record as of July ... a leading supplier of engineered equipment and systems for ...
Cached Medicine Technology:New Test to Screen for Glaucoma Damage 2
... ultrasonic aspirator, portable unit ... aspirator for the fragmentation ... available only outside the ... a very compact design ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Medicine Products: